Discover
PRCT
PROCEPT BioRobotics Corporation
23.47
2 x 17.26
2 x 29.79
bid
ask
+
0.89
3.94%
2 @ 04:00 PM
23.35 -0.12 (0.51%)
| Ytd | -25.40% | |
| 1y | -58.51% |
22.89
day range
24.20
19.35
52 week range
62.17
| Open | 22.93 | Prev Close | 22.58 | Low | 22.89 | High | 24.20 | Mkt Cap | 1.34B |
| Vol | 1.31M | Avg Vol | 1.54M | EPS | -1.83 | P/E | N/A | Forward P/E | -25.95 |
| Beta | 0.85 | Short Ratio | 5.45 | Inst. Own | 102.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-29 | 50-d Avg | 25.18 | 200-d Avg | 29.34 | 1yr Est | 30.20 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-04-29 | 2026-03 | 0 | N/A | -0.01 | -1.82% |
| 2026-02-25 | 2025-12 | 0 | N/A | -0.21 | -65.63% |
| 2026-02-25 | 2025-12 | 0 | N/A | N/A | N/A |
| 2025-11-04 | 2025-09 | 0 | N/A | N/A | N/A |
| 2025-11-04 | 2025-09 | 0 | N/A | 0.03 | 7.32% |
| 2025-08-06 | 2025-06 | 0 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-06-24 | Evercore ISI Group | Upgrade | Outperform | |
| 2026-06-11 | Leerink Partners | Downgrade | Outperform | Market Perform |
| 2026-04-30 | Piper Sandler | Upgrade | Overweight | Overweight |
| 2026-03-06 | Baird | Upgrade | Neutral | |
| 2026-03-02 | Truist Securities | Upgrade | Buy | Buy |
| 2026-02-26 | Leerink Partners | Upgrade | Outperform | Outperform |
Profile
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2026-06-08 | DESAI ANTAL ROHIT | Director | 38.47K | Stock Award(Grant) |
| 2026-06-08 | GARRETT MARY | Director | 17.70K | Stock Award(Grant) |
| 2026-06-08 | HARRIS TAYLOR C | Director | 102.49K | Stock Award(Grant) |
| 2026-06-08 | MOLL FREDERIC H | Director | 866.47K | Stock Award(Grant) |
| 2026-06-07 | NOURI ALALEH | Officer | 105.07K | Sale |
| 2025-06-05 | SHIBLAQ HISHAM | Officer | 63.13K | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | Blackrock Inc. | 4.36M | 102.38M | 7.66% |
| 2026-03-30 | T. Rowe Price Investment Management, Inc. | 3.27M | 76.84M | 5.75% |
| 2026-03-30 | BNP Paribas Asset Management Holding S.A. | 3.09M | 72.51M | 5.43% |
| 2026-03-30 | Vanguard Portfolio Management LLC | 2.42M | 56.83M | 4.25% |
| 2026-03-30 | Vanguard Capital Management LLC | 2.40M | 56.31M | 4.21% |
| 2026-03-30 | Chicago Capital, LLC | 2.16M | 50.71M | 3.80% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.68M | 39.44M | 2.95% |
| 2026-03-30 | T. Rowe Price Small-Cap Stock Fund, Inc. | 1.32M | 30.97M | 2.32% |
| 2026-04-29 | iShares Trust-iShares Russell 2000 ETF | 1.25M | 29.38M | 2.20% |
| 2026-03-30 | VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.24M | 29.00M | 2.17% |
| 2026-03-30 | T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 695.94K | 16.33M | 1.22% |
| 2026-03-30 | VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 690.62K | 16.21M | 1.21% |